Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus

• Status: Unknown status
• Trial end date: 2012-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to study the use of ganciclovir gel 0.3% for treatment of conjunctivitis caused by adenovirus.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Adapt Produtos Oftalmológicos Ltda.
• Treatments: Ganciclovir; Ganciclovir triphosphate; Lubricant Eye Drops

Criteria

Inclusion Criteria:

• Patients with eye disease with a clinical diagnosis of adenovirus conjunctivitis.

• Patients of both gender aged over 18 years.

• Patients who are not pregnant or nursing.

• Patients able (legally and mentally) to understand and sign informed consent had been signed.

Exclusion Criteria:

• Patients who are in the presence of corticosteroids, either by topical ocular, periocular, intraocular or systemic, for less than 30 days of enrollment and who can not make a drug suspension.

• Patients with serious systemic diseases like AIDS, cancer, etc., which in the opinion of the investigator, may put the patient at risk.

• Patient with a single eye or vision in one eye.